期刊文献+

CHA2DS2-VASc评分与非瓣膜病阵发性心房颤动转为持续性心房颤动的关系 被引量:10

Relationship between CHA2DS2-VASc scores and paroxysmal atrial fibrillation converted to persistent atrial fibrillation events in patients with nonrheumatic heart disease
原文传递
导出
摘要 A2DS2-VASc评分系统提出的初衷为评估心房颤动(房颤)发生血栓栓塞事件风险,指导抗凝治疗,并替代原先的CHADS2评分系统[1-2].该评分系统中除"心力衰竭"及"血栓栓塞、脑卒中或一过性脑缺血"为房颤并发症外,其余兼为房颤发生的高危因素[2-3],但CHA2DS2-VASc评分与房颤的进展关系尚未明确.本研究探讨CHA2DS2-VASc评分对阵发性房颤转为持续性房颤的预测价值.
出处 《中华心律失常学杂志》 2013年第5期376-377,共2页 Chinese Journal of Cardiac Arrhythmias
基金 宁波市镇海区社会发展科技项目(2012S1008)
  • 相关文献

参考文献10

  • 1黄从新,张澍,马长生,杨延宗,黄德嘉,曹克将,江洪,杨新春,吴书林,商丽华,华伟,张奎俊,李莉,丁燕生,马坚,王祖禄,刘少稳,刘旭,董建增,姚焰,陈柯萍,陈明龙,吴立群,廖德宁,黄鹤,李述峰,吴钢,蒋晨阳,王方正,陈新.心房颤动:目前的认识和治疗建议——2012[J].中华心律失常学杂志,2012,16(4):246-289. 被引量:209
  • 2黄从新,张澍,马长生,杨延宗,黄德嘉,曹克将,江洪,杨新春,吴书林,商丽华,张奎俊,李莉,丁燕生,马坚,王祖禄,刘少稳,刘旭,董建增,姚焰,陈柯萍,陈明龙,王方正,陈新.心房颤动:目前的认识和治疗建议-2010[J].中华心律失常学杂志,2010,14(5):328-369. 被引量:93
  • 3Kirchhof P,Lip GYH,Van Gelder IC,et al.Comprehensive risk reduction in patients with atrial fibrillation:emerging diagnostic and thera-peutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Europace,2011,14:8-27.
  • 4Zhuang J,Wang Y,Tang K,et al.Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation:a systematic review and meta-analysis of observational studies.Europace,2011,14:638-645.
  • 5Ausma J,Velden HMW,Lenders MH,et al.Reverse structural and gapjunctional remodeling after prolonged atrial fibrillation in the goat.Circulation,2003,107:2051-2058.
  • 6Nattel S,Burstein B,Dobrev D.Atrial remodeling and atrial fibrillation:mechanisms and implications.Cir Arrhythm Electrophysio1,2008,1:62-73.
  • 7Kochiadakis GE,Igoumenidis NE,Hamilos ME,et al.A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.Am J Cardiol,2007,99:1721-1725.
  • 8Komatsu T,Tachibana H,Sato Y,et al.Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-Term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation.Intem Heart J,2010,51:98-104.
  • 9Roy D,Talajic M,Dorian P,et al.Amiodarone to prevent recurrence ofatrial fibrillation.Canadian Trial of Atrial Fibrillation Investigators.N Engl J Med,2000,342:913-920.
  • 10Ouyang F,Tilz R,Chun J,et al.Long-term results of catheter ablation in paroxysmal atrial fibrillation:lessons from a 5-year follow-up.Circulation,2010,122:2368-2377.

二级参考文献43

共引文献298

同被引文献52

  • 1张大喜,李红祥,刘献华,等.房颤119例抗凝治疗现状分析[J].医学信息,2013(29):490-490.
  • 2王方芳,韩江莉.非瓣膜病性心房颤动预防脑卒中的药物治疗新进展[J].中华临床医师杂志2013,7(2):769-772.
  • 3Carom A J, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: The task force for the manage- ment of atrial fibrillation of the European Society of Cardiology (ESC) [J]. Euro Heart J, 2010,31 (10):2369-2429.
  • 4de Castro FD, Chaves PC, Leite-Moreira AF. Cardlorenal syndrome and i's patho- physiological implications [J]. Rev Port Cardiol, 2010,29(10): 1535-1554.
  • 5Khatami MR. lschemic nephropathy: more than a simple renal artery narrowing[J]. Iran J Kidney Dis, 2013, 7(2):82-100.
  • 6lguchi Y, Kimura K, Kobayashi K, et al. Relation of atrial fibrillation to glomerularfiltration rate[J]. Am J Cardiol, 2008,102 (8):1056-1059.
  • 7Go Alan S, Yang Jingrong, Ackerson Lynn, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure the anemia in chronic heart failure:out-comes and resour utilization (ANCHOR) study[J]. Circulation, 2006,113(23):2713-2723.
  • 8Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treat- ment and development of worsing renal function among hospitalized patients [J]. Am Heart J, 2004,147(2): 331-338.
  • 9Chittineni H, Miyawaki N, Gulipeli S, et al. Risk for acute renal failure in patients hospitalized for decompensated conges- tive heart failure[J]. Am J Nephrol, 2007, 27(1):55-62.
  • 10Bergmann MW, Landmesser U. Left atrial appendage closure for stroke prevention in non - valvular atrial fibrillation: rationale, devices in clin- ical development and insights into implantation techniques[J]. EuroInt- ervention, 2014-, 10 (4-) :497 - 504.

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部